Coronary Aneurysms After Drug-Eluting Stent Implantation. Clinical, Angiographic, and Intravascular Ultrasound Findings

Journal of the American College of Cardiology

Volumn 53, Issue 22, 2009, Pages 2053-2060

  Alfonso, Fernando ^a   Pérez Vizcayno, Maria José ^a   Ruiz, Miguel ^a   Suárez, Alfonso ^a   Cazares, Miguel ^a   Hernández, Rosana ^a   Escaned, Javier ^a   Bañuelos, Camino ^a   Jiménez Quevedo, Pilar ^a   Macaya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

angiography; coronary aneurysm; drug eluting stents; intravascular ultrasound

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CLOPIDOGREL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; DISEASE COURSE; DRUG ELUTING STENT; DRUG SAFETY; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; LONG TERM CARE; MALE; PRIORITY JOURNAL; RESTENOSIS; SEPSIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; CONFIDENCE INTERVALS; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DATABASES AS TOPIC; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65649097633     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.01.069     Document Type: Article

References (32)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Mauri L., Hsieh W., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
3. Baz J.A., Pinar E., Albarrán A., and Mauri J. Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007). Rev Esp Cardiol 61 (2008) 1298-1314
4. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
5. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
6. Iakovow I., Schmidt T., Bonizzoni E., et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
7. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 47 (2006) 2112-2115
8. Tanabe K., Serruys P.W., Degertekin M., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare-metal stents. Insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905
9. Ako J., Morino Y., Honda Y., et al. Late incomplete stent apposition after sirolimus-eluting stent implantation. A serial intravascular ultrasound analysis. J Am Coll Cardiol 46 (2005) 1002-1005
10. Hong M.K., Mintz G.S., Lee C.W., et al. Late stent malapposition after drug-eluting stent implantation. An intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
11. Kimura M., Mintz G.S., Carlier S., et al. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 98 (2006) 436-442
12. Aoki J., Kirtane A., Leon M.B., and Dangas G. Coronary artery aneurysm after drug-eluting stent implantation. J Am Coll Cardiol Intv 1 (2008) 14-21
13. Stabile E., Escobar E., Weigold G., et al. Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation. Circulation 110 (2004) e47-e48
14. Li S.S.L., Cheng B.C., and Lee S.H. Giant coronary aneurysm formation after sirolimus-eluting stent implantation in Kawasaki disease. Circulation 112 (2005) e105-e107
15. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we be cautious?. Circulation 109 (2004) 701-705
16. Bavry A.A., Chiu J.H., Jefferson B.K., et al. Development of coronary aneurysm after drug-eluting stent implantation. (letter). Ann Intern Med 146 (2007) 230-232
17. Alfonso F., Moreno R., and Vergas J. Fatal infection after rapamycin-eluting coronary stent implantation. Heart 91 (2005) e51-e52
18. Singh H., Singh C., Aggarwal N., Dugal J.S., Kumar A., and Luthra M. Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: a case report. Catheter Cardiovasc Interv 65 (2005) 282-285
19. Le M.Q., and Narins C.R. Mycotic pseudoaneurysm of the left circumflex coronary artery: a fatal complication following drug-eluting stent implantation. Catheter Cardiovasc Interv 69 (2007) 508-512
20. Marcu C.B., Balf D.V., and Donouhe T.J. Post-infectious pseudoaneurysm after coronary angioplasty using drug-eluting stents. Heart Lung Circ 14 (2005) 85-86
21. Jang J.J., Krishnaswami A., Fang J., Go M., and Ben V.C. Pseudoaneurysm and intracardiac fistula caused by an infected paclitaxel-eluting coronary stent. Circulation 116 (2007) e364-e365
22. Alfonso F., García P., Fleites H., et al. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis: angiographic and intravascular ultrasound findings of a randomized study. Am Heart J 149 (2005) 149.e1-149.e8
23. Alfonso F., Suarez A., Angiolillo D.J., et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 90 (2004) 1455-1459
24. Dawkins K.D., Grube E., Guagliumi G., et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
25. Biondi-Zoccai G.S., Agostoni P., Sangiorgi G.M., et al. Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation. Eur Heart J 27 (2006) 540-546
26. Alfonso F. Residual coronary dissections after drug-eluting stenting: the good, the bad, and the ugly. Eur Heart J 27 (2006) 503-505
27. Rab S.T., King III S.B., Roubin G.S., Carlin S., Hearn J.A., and Douglas Jr. J.S. Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18: (1991) 1524-1528
28. Kritharides L., Yiannikas J., Brieger D., and Allman K. Coronary uptake of gallium-67 citrate after implantation of sirolimus-eluting stent. Circulation 109 (2004) 2156
29. Nebeker J.R., Virmani R., Bennett C.L., et al. Hypersensitivity cases associated with drug-eluting coronary stents. A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) Project. J Am Coll Cardiol 47 (2006) 175-181
30. van der Hoeven B.L., Liem S.S., Jukema J.W., et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome. J Am Coll Cardiol 51 (2008) 618-626
31. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
32. Alfonso F., Suarez A., Pérez-Vizcayno M.J., et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 21 (2007) 2095-2099